AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Imaging Speech in Neurotypical Adults and Individuals With Cerebellar Stroke

RecruitingNAAges 18 Years - anyAllUniversity of Pittsburgh
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this research study is to learn how the brain areas that plan and control movement interact with the areas responsible for hearing and perceiving speech in healthy adults and people who have had cerebellar strokes. The main questions it aims to answer are: 1. What regions of the brain's sensory systems show changes in their activity related to speech? 2. To what extent do these regions help listeners detect and correct speech errors? 3. What is the role of the cerebellum (a part of the brain in the back of the head) in these activities? Participants will be asked to complete several experimental sessions involving behavioral speech and related tests and non-invasive brain imaging using electroencephalography (EEG) and functional magnetic resonance imaging (fMRI).

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Cohort 1 (neurotypical adults): * Age 18-49 * Right-handed * Native English speaker Cohort 2 (people with cerebellar lesions): * Age 18 or older * Right-handed * Native English speaker * History of cerebellar stroke Cohort 3 (controls matched to Cohort 2) * Age 18 or older * Right-handed * Native English speaker Exclusion Criteria: Cohort 1 (neurotypical adults): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury (e.g., stroke or severe traumatic brain injury) * Hearing loss, defined by pure tone thresholds \>25 decibels (dB) hearing level (HL) at octave frequencies between 250-8000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Clinically diagnosed with or treated for a speech, language, or hearing disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant Cohort 2 (people with cerebellar lesions): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury other than stroke * Hearing loss, defined by pure tone thresholds \>50 dB HL at octave frequencies between 250-4000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant Cohort 3 (controls matched to Cohort 2): * Presence of MRI risk factors: metal and/or electromagnetic devices (e.g., pacemakers, neurostimulators) in the body, previous shrapnel injuries, use of an intrauterine device containing metal, claustrophobia, pregnant or possibly pregnant * History of neurological / neurodegenerative disease or severe brain injury (e.g., stroke or severe traumatic brain injury) * Hearing loss, defined by pure tone thresholds \>50 dB HL at octave frequencies between 250-4000 Hz * Clinical diagnosis and/or treatment for schizophrenia or other psychotic disorders * Clinical diagnosis and/or treatment for neurocognitive disorders (e.g., dementia, delirium) * Presence of a severe and unmanaged, clinically diagnosed attention disorder * Clinically diagnosed with or treated for a speech, language, or hearing disorder * Head circumference greater than 60cm or weight greater than 300 pounds * History of severe claustrophobia * Currently pregnant
๐Ÿ’Š

What it tests

  • Neural responses to speech functional localizer
  • Neural responses to silent articulation
  • Neural responses to self vs. externally generated speech
  • Event-related potentials for speech
  • Neural responses to induced speech errors
๐Ÿ“

Where

1 site
University of Pittsburgh
Pittsburgh, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy